Pharmacotherapy for resistant hypertension in adults

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of adding a new drug to the current triple‐drug regimen for management of resistant hypertension in adults versus continuation of treatment with triple‐drug therapy alone.